These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 224594)

  • 1. Enhancement of Epstein-Barr virus replication in producer cell lines by a combination of low temperature and corticosteroids.
    Magrath IT; Pizzo PA; Novikovs L; Levine AS
    Virology; 1979 Sep; 97(2):477-81. PubMed ID: 224594
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of hydrocortisone and bromodeoxyuridine (BUdR) on the Epstein-Barr herpes virus in human lymphoblastoid cell lines.
    Joncas JH; Leyritz M
    Rev Can Biol; 1974 Jun; 33(2):135-47. PubMed ID: 4369295
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of hydrocortisone on the synthesis of Epstein-Barr virus antigens in P3HR-1 cells.
    Prachová K; Roubal J
    Acta Virol; 1981 May; 25(3):163-6. PubMed ID: 6115566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of Epstein-Barr virus early antigen, virus capsid antigen and virus DNA synthesis by mitomycin C.
    Ernberg I; Moar MH
    J Gen Virol; 1981 Jan; 52(Pt 1):39-48. PubMed ID: 6267175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of hydrocortisone on cell viability, Epstein-Barr virus genome expression, and interferon synthesis in human lymphoblastoid cell lines.
    Joncas J; Boucher J; Boudreault A; Granger-Julien M
    Cancer Res; 1973 Sep; 33(9):2142-8. PubMed ID: 4353485
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibition of productive replication of Epstein-Barr virus DNA by phosphonoacetic acid.
    Yajima Y; Tanaka A; Nonoyama M
    Virology; 1976 May; 71(1):352-4. PubMed ID: 179207
    [No Abstract]   [Full Text] [Related]  

  • 7. Sequence of Epstein-Barr virus productive cycle in human lymphoblastoid cells.
    Hampar B; Derge JG; Tanaka A; Nonoyama M
    Cold Spring Harb Symp Quant Biol; 1975; 39 Pt 2():811-5. PubMed ID: 169035
    [No Abstract]   [Full Text] [Related]  

  • 8. Transforming activity of Epstein-Barr virus obtained by superinfection of Raji cells.
    Yajima Y; Marczynska B; Nonoyama M
    Proc Natl Acad Sci U S A; 1978 Apr; 75(4):2008-10. PubMed ID: 205877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the diterpene ester TPA on Epstein-Barr virus antigen- and DNA synthesis in producer and nonproducer cell lines.
    Hudewentz J; Bornkamm GW; Zur Hausen H
    Virology; 1980 Jan; 100(1):175-8. PubMed ID: 6243196
    [No Abstract]   [Full Text] [Related]  

  • 10. Intracellular state of Epstein-Barr virus DNA in producer cell lines.
    Gussander E; Adams A
    J Gen Virol; 1979 Nov; 45(2):331-40. PubMed ID: 232128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial elimination of latent Epstein-Barr virus genomes from virus-producing cells by cyclohexamide.
    Tanaka A; Nonoyama M; Hampar B
    Virology; 1976 Mar; 70(1):164-70. PubMed ID: 176800
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction of Epstein-Barr virus-related membrane antigens by 5-iododeoxyuridine in non-producer human lymphoblastoid cells.
    Sugawara K; Mizuno F; Osato T
    Nat New Biol; 1973 Nov; 246(151):70-2. PubMed ID: 4357308
    [No Abstract]   [Full Text] [Related]  

  • 13. Sensitivity of the Epstein-Barr virus transformed human lymphoid cell lines to interferon.
    Adams A; Strander H; Cantell K
    J Gen Virol; 1975 Aug; 28(2):207-17. PubMed ID: 170370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of Epstein-Barr virus nuclear antigen(s) in different cell lines by radioimmunoelectrophoresis.
    Sculley TB; Spelsberg TC; Pearson GR
    Intervirology; 1984; 22(4):191-200. PubMed ID: 6096291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of the Epstein-Barr virus (EBV) cycle in latently infected cells by n-butyrate.
    Luka J; Kallin B; Klein G
    Virology; 1979 Apr; 94(1):228-31. PubMed ID: 220786
    [No Abstract]   [Full Text] [Related]  

  • 16. Modes of Epstein-Barr virus infection in human floating cell lines.
    Sairenji T; Hinuma Y
    Gan; 1973 Dec; 64(6):583-90. PubMed ID: 4360583
    [No Abstract]   [Full Text] [Related]  

  • 17. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes.
    Miller G; Lipman M
    Proc Natl Acad Sci U S A; 1973 Jan; 70(1):190-4. PubMed ID: 4346033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Infection of the human T-cell-derived leukemia line Molt-4 by Epstein-Barr virus (EBV): induction of EBV-determined antigens and virus reproduction.
    Shapiro IM; Volsky DJ; Saemundsen AK; Anisimova E; Klein G
    Virology; 1982 Jul; 120(1):171-81. PubMed ID: 6285596
    [No Abstract]   [Full Text] [Related]  

  • 19. Chloroquine enhances Epstein-Barr virus expression.
    Karmali RA; Horrobin DF; Menezes J; Patel P; Musto J
    Nature; 1978 Oct; 275(5679):444-5. PubMed ID: 211434
    [No Abstract]   [Full Text] [Related]  

  • 20. Radioimmune precipitation study comparing the Epstein-Barr virus membrane antigens expressed on P3HR-1 virus-superinfected Raji cells to those expressed on cells in a B-95 virus-transformed producer culture activated with tumor-promoting agent (TPA).
    Qualtiere LF; Pearson GR
    Virology; 1980 Apr; 102(2):360-9. PubMed ID: 6245514
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.